Cargando…

An overview on the investigation of nanomaterials' effect on plasma components: immunoglobulins and coagulation factor VIII, 2010–2020 review

FVIII and immunoglobulins (Igs) are the most prominent plasma proteins, which play a vital role in plasma hemostasis. These proteins have been implemented frequently in protein therapy. Therefore, their maintenance, durability, and stability are highly essential. Herein, various approaches to improv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zadeh Mehrizi, Tahereh, Mousavi Hosseini, Kamran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419877/ https://www.ncbi.nlm.nih.gov/pubmed/36133015 http://dx.doi.org/10.1039/d1na00119a

Ejemplares similares

Effects and treatment applications of polymeric nanoparticles on improving platelets’ storage time: a review of the literature from 2010 to 2020
por: Mehrizi, Tahereh Zadeh, et al.
Publicado: (2021)

Detection of Fibrinogen and Coagulation Factor VIII in Plasma by a Quartz Crystal Microbalance Biosensor
por: Yao, Chunyan, et al.
Publicado: (2013)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1
por: Kannicht, Christoph, et al.
Publicado: (2017)

Comparative analysis of activity of coagulation Factors V and VIII and level of fibrinogen in fresh frozen plasma and frozen plasma
por: Dogra, Mitu, et al.
Publicado: (2015)

Development and Characterization of Recombinant Ovine Coagulation Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2012)

Bacterial Production of Recombinant Coagulation Factor VIII Domains
por: Bashar, Saima, et al.
Publicado: (2023)

Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
por: Doshi, Bhavya S., et al.
Publicado: (2012)

Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII
por: Sayyadipour, Fatemeh, et al.
Publicado: (2020)

Application of non-metal nanoparticles, as a novel approach, for improving the stability of blood products: 2011–2021
por: Zadeh Mehrizi, Tahereh, et al.
Publicado: (2022)

Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2017)

Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes
por: Dalm, Daniela, et al.
Publicado: (2015)

Human coagulation factor VIII domain-specific recombinant polypeptide expression
por: Choi, Su Jin, et al.
Publicado: (2015)

Study on Coagulation Factor VIII and Fibrinogen Levels in Patients with Thyroid Disorders
por: Thoyyib, Muhammed, et al.
Publicado: (2018)

Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII
por: Firrman, Jenni, et al.
Publicado: (2020)

Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease
por: Pradhan-Sundd, Tirthadipa, et al.
Publicado: (2021)

Characterization and visualization of murine coagulation factor VIII-producing cells in vivo
por: Hayakawa, Morisada, et al.
Publicado: (2021)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Overview of the coagulation system
por: Palta, Sanjeev, et al.
Publicado: (2014)

Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome
por: Sasaki, Ritsuko, et al.
Publicado: (2018)

Implementation of Plasma Fractionation in Biological Medicines Production
por: Mousavi Hosseini, Kamran, et al.
Publicado: (2016)

Effect of plasma component transfusion on conventional coagulation screening tests
por: Raturi, Manish, et al.
Publicado: (2018)

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma
por: Ping, Zheng, et al.
Publicado: (2017)

Protein residue network analysis reveals fundamental properties of the human coagulation factor VIII
por: Lopes, Tiago J. S., et al.
Publicado: (2021)

Argon plasma coagulation is not effective in every vascular lesion
por: Chauhan, Himadri, et al.
Publicado: (2016)

CELL SURFACE IMMUNOGLOBULIN : VIII. SYNTHESIS, SECRETION, AND CELL SURFACE EXPRESSION OF IMMUNOGLOBULIN IN MURINE THORACIC DUCT LYMPHOCYTES
por: Uhr, Jonathan W., et al.
Publicado: (1974)

An Overview of Nanomaterial Applications in Pharmacology
por: Roy, Madhura, et al.
Publicado: (2023)

Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study
por: Venkateswarlu, Divi
Publicado: (2010)

Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
por: van Haren, Simon D., et al.
Publicado: (2013)

Progress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution
por: Shim, Ye Jee, et al.
Publicado: (2014)

Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat
por: Rasmussen, Caroline E., et al.
Publicado: (2017)

Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan
por: Konishi, Akiko, et al.
Publicado: (2020)

Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII
por: Yen, Chih-Ching, et al.
Publicado: (2022)

Acknowledgment to Reviewers of Nanomaterials in 2020
Publicado: (2021)

Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010–2020
por: Bahar, Enas, et al.
Publicado: (2022)

Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice
por: Sarafanov, Andrey G.
Publicado: (2023)

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
por: Casademunt, Elisabeth, et al.
Publicado: (2012)

Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides
por: Fang, Han, et al.
Publicado: (2019)

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity
por: Zhao, Ying, et al.
Publicado: (2017)

Coagulation factor VIII, white matter hyperintensities and cognitive function: Results from the Cardiovascular Health Study
por: Rohmann, Jessica L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8534r9fgpuf3anqm19t1p99u2n